Fluidigm Raises $18.2M in Private Stock Sale | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm has raised $18.2 million through the private placement of an undisclosed number of shares, according to a filing with the US Securities and Exchange Commission.

The South San Francisco, Calif.-based firm is seeking to raise up to a total of $24.1 million from the offering, according to the SEC filing.

A Fluidigm spokesman confirmed the amount of money raised so far, but he could not provide any further details at this time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.